Br

Breast

The Breast is a multidisciplinary open access journal for researchers and clinicians focusing on translational and clinical research for the advancement of breast cancer prevention, diagnosis, and treatment of all stages. It publishes original research articles, systematic reviews, viewpoints/commentaries, debate articles, and correspondences on pre-malignant and malignant breast disease, including epidemiology, translational research, imaging, oncology, surgery, psycho-oncology, quality of life, survivorship, supportive care, palliative care, advocacy, nursing, and breast care management.

Looking to publish in Breast? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Obstetrics & Gynecology, Oncology
Impact Factor 7.9
Quartile Q1
Open Access Type Open
ISSN 0960-9776
eISSN 1532-3080
Invitation Only No
Cost Range Article Publishing Charge: USD 3770 for Original Research Articles and Reviews; USD 1670 for Short Communications, Debates, Viewpoints, and Case Reports.

Submission Instructions

Breast accepts the following article types. Click on an article type to view submission instructions.

Original Research Papers

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required for Original Research Papers. Abstract must not exceed 250 words.
Manuscript Text of the paper must not exceed 3,000 words, excluding the abstract, references, tables, and captions. Manuscript must include 1 to 7 keywords, article highlights of 3 to 5 bullet points, a competing interests declaration, and a generative AI declaration in a new section before the references list.
References References must be cited in the text using numbers in square brackets, listed in reference-list order of appearance, and for works with more than 6 authors the first 6 authors should be listed followed by 'et al.'.
Figures & Tables Tables must be submitted as editable text and figures must be supplied as separate files along with the manuscript. All tables and figures must be cited in the text, numbered consecutively in order of appearance, and provided with captions.
Reformat to Breast using Livewrite Premium

Review Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required for Review Articles. Abstract must not exceed 250 words.
Manuscript Review Articles must not exceed 5,000 words in length. Review Articles should be topical and not just an overview of the literature. Manuscript must include 1 to 7 keywords, article highlights of 3 to 5 bullet points, a declarations section completed before the references list including any generative AI use statement, and acknowledgements in a separate section directly before the references list.
References References must be cited as numbers in square brackets, listed in the reference list in order of appearance, include standard bibliographic details, and list the first 6 authors followed by 'et al.' when there are more than 6 authors.
Figures & Tables Tables must be submitted as editable text and figures must be supplied as separate files along with the manuscript. All tables and figures must be cited in the text, numbered consecutively in order of appearance, and provided with captions.
Reformat to Breast using Livewrite Premium

Systematic Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must not exceed 250 words.
Manuscript The manuscript submission must include 1 to 7 keywords, article highlights of 3 to 5 bullet points, and a declaration of generative AI use in a section placed before the references list.
References References must be cited as numbers in square brackets and listed in numerical order of appearance. References may be in any consistent style at submission, must include core bibliographic details, and for works with more than 6 authors the first 6 should be listed followed by 'et al.'.
Figures & Tables Tables should be provided as editable text and figures should be supplied as separate files. All tables and figures must be cited in the text, numbered consecutively in order of appearance, and accompanied by captions.
Reformat to Breast using Livewrite Premium

Short Communications

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must not exceed 250 words. Abstract format is not specified.
Manuscript Short Communications should not exceed 1,000 words in length. Short Communications should follow the structure of an original research paper. The manuscript must include 1 to 7 keywords, article highlights of 3 to 5 bullet points, and a declaration of generative AI use in a section placed before the references list.
References References must be cited as numbers in square brackets, listed in reference-list order of appearance, and for works with more than 6 authors the first 6 authors should be listed followed by 'et al.'.
Figures & Tables Figures must be supplied as separate files, while tables must be submitted as editable text. Tables must be cited in the text, numbered consecutively, and include captions.
Reformat to Breast using Livewrite Premium

Correspondence

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Correspondence letters must be 200 words or less. Correspondence must relate to published work in Breast. A declaration of generative AI and AI-assisted technologies used in manuscript preparation must be included in a new section before the references list.
References References must be cited by numbers in square brackets and listed in the reference list in order of appearance. References may be in any consistent style at submission, and references with more than 6 authors must list the first 6 followed by 'et al.'.
Figures & Tables Figures and other graphical media must be supplied as separate files along with the manuscript. Tables must be submitted as editable text rather than images and must include captions.
Reformat to Breast using Livewrite Premium

Recent Publications

Health-related quality of life with pertuzumab retreatment: Secondary analysis of the PRECIOUS trial

Naruto Taira, Yutaka Yamamoto, Hiroji Iwata, Shigehira Saji, Masato Takahashi, Tetsuhiro Yoshinami, Takayuki Ueno, Tatsuya Toyama, Toshimi Takano, Masahiro Kashiwaba, Koichiro Tsugawa, Hiroshi Tada, Fumikata Hara, Tomomi Fujisawa, Naoki Niikura, Satoshi Morita, Norikazu Masuda

10.1016/j.breast.2026.104790
View Publication

From CDK4/6 to CDK2 and KAT: Evolving therapeutic approaches in HR+/HER2– breast cancer

Paulina Stachyra, Cristina Hernando Meliá, José Antonio López-Guerrero, Joaquín Gavilá Gregori, Ángel Luis Guerrero-Zotano

10.1016/j.breast.2026.104791
View Publication

24-week home-based walking program in the early adjuvant setting in breast cancer patients who receive aromatase inhibitor endocrine therapy: lessons learned from the SAKK 95/17 WISE prospective, randomized, multicenter trial

Uwe Güth, Nicolette Hoefnagels, Andreas Müller, Sämi Schär, Laurent Rosset, Mahbiz Nobahar Corke, Michael Schwitter, Andreas Jakob, Cathrin Balmelli, Cornelia Leo, Matthias Fehr, David R. Thorn, Salome Riniker, Amina Chouiter-Djebaili, Jana Musilova, Karin Ribi, Friedemann Honecker

10.1016/j.breast.2026.104789
View Publication

Incidence of lymphomas in a nationwide prospective cohort study of breast-implanted women

Julie Kalstrup, Lene Mellemkjær, Lene Wohlfahrt Dreyer, Trine Lønbo Grantzau, Trine Foged Henriksen, Alexander Egeberg, Tobias Strømgren, Thomas Scheike, Peter de Nully Brown, Lisbet Rosenkrantz Hölmich

10.1016/j.breast.2026.104792
View Publication

HER2-directed therapy is associated with an increased rate of cardiologic emergency department visits in real-world breast cancer patients

Sandra Mayer, Anna Pfarrhofer, Sophie M. Neubauer, Sabina Pasalic, Georg Jeryczynski, Maximilian Marhold, Gerwin Heller, Jutta Bergler-Klein, Andreas Spannbauer, Thorsten Fuereder, Filippo Cacioppo, Anton Laggner, Matthias Preusser, Rupert Bartsch, Christoph Minichsdorfer

10.1016/j.breast.2026.104795
View Publication

Frequently asked questions

How long does it take to publish?

13 days submission to first decision; 55 days submission to decision after review; 89 days submission to acceptance; 2 days acceptance to online publication

Reformat to Breast using Livewrite Premium

What are the publication costs?

Article Publishing Charge: USD 3770 for Original Research Articles and Reviews; USD 1670 for Short Communications, Debates, Viewpoints, and Case Reports.

Reformat to Breast using Livewrite Premium

Research Topics

Breast Cancer Treatment Studies Breast Lesions and Carcinomas Cancer Treatment and Pharmacology Global Cancer Incidence and Screening HER2/EGFR in Cancer Research Advanced Breast Cancer Therapies Breast Implant and Reconstruction Estrogen and related hormone effects BRCA gene mutations in cancer Cancer Risks and Factors Cancer survivorship and care Cancer Genomics and Diagnostics Economic and Financial Impacts of Cancer Cancer and Skin Lesions Cancer Diagnosis and Treatment Reconstructive Surgery and Microvascular Techniques Medical Imaging Techniques and Applications Radiomics and Machine Learning in Medical Imaging Advances in Oncology and Radiotherapy Male Breast Health Studies Cancer Cells and Metastasis Health Systems, Economic Evaluations, Quality of Life AI in cancer detection Lung Cancer Treatments and Mutations Bone health and treatments

Related Journals

TI
Trends In Anaesthesia And Critical Care Elsevier BV
AI
Artificial Intelligence In Medicine Elsevier BV
IJ
International Journal Of Nursing Studies Elsevier BV
Bi
Biodrugs Adis, Springer Healthcare
RA
Radiotherapy And Oncology Elsevier BV
AJ
American Journal Of Translational Research e-Century Publishing Corporation